In a study by Jahanbani-Ardakani et al., the aim was to assess IL-18 levels and the prevalence of three SNPs (single nucleotide polymorphisms) of IL-18 in the serum of MS patients from Iran [29]. This evidence concerns the gene IL18 and myeloid sarcoma.